Company intelligence / Profile preview
SSY Group
Shijiazhuang, Hebei, Chinassygroup.com.hk ↗
- Ownership
- Private
- Employees
- ~6146
- Development stage
- Other
01
Overview
SSY Group Limited is one of the largest manufacturers of intravenous infusion solutions globally and a leading pharmaceutical company in China. The company has a strong commercial presence with advanced manufacturing capabilities and a broad product portfolio that includes small volume injections, oral preparations, Chinese medicine preparations, biological preparations, and peritoneal dialysis solutions. It recently received NMPA approval for passing consistency evaluation of its peritoneal dialysis solution.
- Therapeutic areas
- NephrologyInfectious Diseases
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Sichuan Kelun Pharmaceutical Co., Ltd. (equity stake)
Beyond the preview
Go deeper on SSY Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SSY Group.